Scan to download
BTC $62,583.11 -0.93%
ETH $1,675.94 -0.15%
BNB $597.62 -0.37%
XRP $1.14 +0.79%
SOL $66.20 -0.39%
TRX $0.3230 -1.14%
DOGE $0.0856 -0.74%
ADA $0.1680 +0.98%
BCH $207.04 +0.47%
LINK $7.90 -0.44%
HYPE $61.93 +0.17%
AAVE $62.37 -2.79%
SUI $0.7569 +0.02%
XLM $0.1981 -1.31%
ZEC $473.55 +12.60%
BTC $62,583.11 -0.93%
ETH $1,675.94 -0.15%
BNB $597.62 -0.37%
XRP $1.14 +0.79%
SOL $66.20 -0.39%
TRX $0.3230 -1.14%
DOGE $0.0856 -0.74%
ADA $0.1680 +0.98%
BCH $207.04 +0.47%
LINK $7.90 -0.44%
HYPE $61.93 +0.17%
AAVE $62.37 -2.79%
SUI $0.7569 +0.02%
XLM $0.1981 -1.31%
ZEC $473.55 +12.60%

The listed company Applied DNA Sciences plans to raise up to $58 million through a private placement to initiate its BNB financial strategy

2025-09-30 11:02:54
Collection

ChainCatcher news, according to businesswire, biotechnology company Applied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has received a commitment for a private investment in public equity (PIPE) led by institutional investors, with a maximum amount of up to $58 million, to initiate a BNB-based digital asset financial strategy.

The company has secured a total of $27 million in funding commitments through PIPE, which includes cash, stablecoins, and OBNB trust units. In the future, by exercising warrants, the company also expects to receive up to $31 million in additional investment, bringing the total fundraising amount to a maximum of $58 million.

The PIPE transaction is expected to be completed around October 1, 2025. To support its BNB reserve strategy, the company has signed a five-year Strategic Digital Asset Services Agreement with Cypress LLC, which will provide full asset management services.

app_icon
ChainCatcher Building the Web3 world with innovations.